0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Needle Free Diabetes Management Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-20I4067
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Needle Free Diabetes Management Market Insights and Forecast to 2028
BUY CHAPTERS

Global Needle Free Diabetes Management Market Research Report 2023

Code: QYRE-Auto-20I4067
Report
March 2023
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Needle Free Diabetes Management Market

The global Needle Free Diabetes Management market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Needle Free Diabetes Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Needle Free Diabetes Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Needle Free Diabetes Management in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Needle Free Diabetes Management include Zogenix, 3M, Antares Pharma Inc., Glide Pharmaceutical Technologies, Injex Pharma AG, Pharmajet, Inc., Bioject Medical Technologies, Medtronic and Johnson & Johnson, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Needle Free Diabetes Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle Free Diabetes Management.
The Needle Free Diabetes Management market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Needle Free Diabetes Management market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle Free Diabetes Management companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Zogenix
  • 3M
  • Antares Pharma Inc.
  • Glide Pharmaceutical Technologies
  • Injex Pharma AG
  • Pharmajet, Inc.
  • Bioject Medical Technologies
  • Medtronic
  • Johnson & Johnson
  • Pancreum LLC
  • Tandem Diabetes Care
  • JDRF
  • Akra Dermojet

Segment by Type

  • Insulin Jet Injector
  • Insulin Pen
  • Insulin Inhaler
  • Insulin Patch & Pump

Segment by Application

  • Hospitals
  • Clinics
  • Other

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Needle Free Diabetes Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Needle Free Diabetes Management Market Report

Report MetricDetails
Report NameGlobal Needle Free Diabetes Management Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Needle Free Diabetes Management Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Insulin Jet Injector
1.2.3 Insulin Pen
1.2.4 Insulin Inhaler
1.2.5 Insulin Patch & Pump
1.3 Market by Application
1.3.1 Global Needle Free Diabetes Management Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Needle Free Diabetes Management Market Perspective (2018-2029)
2.2 Needle Free Diabetes Management Growth Trends by Region
2.2.1 Global Needle Free Diabetes Management Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Needle Free Diabetes Management Historic Market Size by Region (2018-2023)
2.2.3 Needle Free Diabetes Management Forecasted Market Size by Region (2024-2029)
2.3 Needle Free Diabetes Management Market Dynamics
2.3.1 Needle Free Diabetes Management Industry Trends
2.3.2 Needle Free Diabetes Management Market Drivers
2.3.3 Needle Free Diabetes Management Market Challenges
2.3.4 Needle Free Diabetes Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Needle Free Diabetes Management Players by Revenue
3.1.1 Global Top Needle Free Diabetes Management Players by Revenue (2018-2023)
3.1.2 Global Needle Free Diabetes Management Revenue Market Share by Players (2018-2023)
3.2 Global Needle Free Diabetes Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Needle Free Diabetes Management Revenue
3.4 Global Needle Free Diabetes Management Market Concentration Ratio
3.4.1 Global Needle Free Diabetes Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Needle Free Diabetes Management Revenue in 2022
3.5 Needle Free Diabetes Management Key Players Head office and Area Served
3.6 Key Players Needle Free Diabetes Management Product Solution and Service
3.7 Date of Enter into Needle Free Diabetes Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Needle Free Diabetes Management Breakdown Data by Type
4.1 Global Needle Free Diabetes Management Historic Market Size by Type (2018-2023)
4.2 Global Needle Free Diabetes Management Forecasted Market Size by Type (2024-2029)
5 Needle Free Diabetes Management Breakdown Data by Application
5.1 Global Needle Free Diabetes Management Historic Market Size by Application (2018-2023)
5.2 Global Needle Free Diabetes Management Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Needle Free Diabetes Management Market Size (2018-2029)
6.2 North America Needle Free Diabetes Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Needle Free Diabetes Management Market Size by Country (2018-2023)
6.4 North America Needle Free Diabetes Management Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Needle Free Diabetes Management Market Size (2018-2029)
7.2 Europe Needle Free Diabetes Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Needle Free Diabetes Management Market Size by Country (2018-2023)
7.4 Europe Needle Free Diabetes Management Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Needle Free Diabetes Management Market Size (2018-2029)
8.2 Asia-Pacific Needle Free Diabetes Management Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Needle Free Diabetes Management Market Size by Region (2018-2023)
8.4 Asia-Pacific Needle Free Diabetes Management Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Needle Free Diabetes Management Market Size (2018-2029)
9.2 Latin America Needle Free Diabetes Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Needle Free Diabetes Management Market Size by Country (2018-2023)
9.4 Latin America Needle Free Diabetes Management Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Needle Free Diabetes Management Market Size (2018-2029)
10.2 Middle East & Africa Needle Free Diabetes Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Needle Free Diabetes Management Market Size by Country (2018-2023)
10.4 Middle East & Africa Needle Free Diabetes Management Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zogenix
11.1.1 Zogenix Company Detail
11.1.2 Zogenix Business Overview
11.1.3 Zogenix Needle Free Diabetes Management Introduction
11.1.4 Zogenix Revenue in Needle Free Diabetes Management Business (2018-2023)
11.1.5 Zogenix Recent Development
11.2 3M
11.2.1 3M Company Detail
11.2.2 3M Business Overview
11.2.3 3M Needle Free Diabetes Management Introduction
11.2.4 3M Revenue in Needle Free Diabetes Management Business (2018-2023)
11.2.5 3M Recent Development
11.3 Antares Pharma Inc.
11.3.1 Antares Pharma Inc. Company Detail
11.3.2 Antares Pharma Inc. Business Overview
11.3.3 Antares Pharma Inc. Needle Free Diabetes Management Introduction
11.3.4 Antares Pharma Inc. Revenue in Needle Free Diabetes Management Business (2018-2023)
11.3.5 Antares Pharma Inc. Recent Development
11.4 Glide Pharmaceutical Technologies
11.4.1 Glide Pharmaceutical Technologies Company Detail
11.4.2 Glide Pharmaceutical Technologies Business Overview
11.4.3 Glide Pharmaceutical Technologies Needle Free Diabetes Management Introduction
11.4.4 Glide Pharmaceutical Technologies Revenue in Needle Free Diabetes Management Business (2018-2023)
11.4.5 Glide Pharmaceutical Technologies Recent Development
11.5 Injex Pharma AG
11.5.1 Injex Pharma AG Company Detail
11.5.2 Injex Pharma AG Business Overview
11.5.3 Injex Pharma AG Needle Free Diabetes Management Introduction
11.5.4 Injex Pharma AG Revenue in Needle Free Diabetes Management Business (2018-2023)
11.5.5 Injex Pharma AG Recent Development
11.6 Pharmajet, Inc.
11.6.1 Pharmajet, Inc. Company Detail
11.6.2 Pharmajet, Inc. Business Overview
11.6.3 Pharmajet, Inc. Needle Free Diabetes Management Introduction
11.6.4 Pharmajet, Inc. Revenue in Needle Free Diabetes Management Business (2018-2023)
11.6.5 Pharmajet, Inc. Recent Development
11.7 Bioject Medical Technologies
11.7.1 Bioject Medical Technologies Company Detail
11.7.2 Bioject Medical Technologies Business Overview
11.7.3 Bioject Medical Technologies Needle Free Diabetes Management Introduction
11.7.4 Bioject Medical Technologies Revenue in Needle Free Diabetes Management Business (2018-2023)
11.7.5 Bioject Medical Technologies Recent Development
11.8 Medtronic
11.8.1 Medtronic Company Detail
11.8.2 Medtronic Business Overview
11.8.3 Medtronic Needle Free Diabetes Management Introduction
11.8.4 Medtronic Revenue in Needle Free Diabetes Management Business (2018-2023)
11.8.5 Medtronic Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Detail
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Needle Free Diabetes Management Introduction
11.9.4 Johnson & Johnson Revenue in Needle Free Diabetes Management Business (2018-2023)
11.9.5 Johnson & Johnson Recent Development
11.10 Pancreum LLC
11.10.1 Pancreum LLC Company Detail
11.10.2 Pancreum LLC Business Overview
11.10.3 Pancreum LLC Needle Free Diabetes Management Introduction
11.10.4 Pancreum LLC Revenue in Needle Free Diabetes Management Business (2018-2023)
11.10.5 Pancreum LLC Recent Development
11.11 Tandem Diabetes Care
11.11.1 Tandem Diabetes Care Company Detail
11.11.2 Tandem Diabetes Care Business Overview
11.11.3 Tandem Diabetes Care Needle Free Diabetes Management Introduction
11.11.4 Tandem Diabetes Care Revenue in Needle Free Diabetes Management Business (2018-2023)
11.11.5 Tandem Diabetes Care Recent Development
11.12 JDRF
11.12.1 JDRF Company Detail
11.12.2 JDRF Business Overview
11.12.3 JDRF Needle Free Diabetes Management Introduction
11.12.4 JDRF Revenue in Needle Free Diabetes Management Business (2018-2023)
11.12.5 JDRF Recent Development
11.13 Akra Dermojet
11.13.1 Akra Dermojet Company Detail
11.13.2 Akra Dermojet Business Overview
11.13.3 Akra Dermojet Needle Free Diabetes Management Introduction
11.13.4 Akra Dermojet Revenue in Needle Free Diabetes Management Business (2018-2023)
11.13.5 Akra Dermojet Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Needle Free Diabetes Management Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Insulin Jet Injector
    Table 3. Key Players of Insulin Pen
    Table 4. Key Players of Insulin Inhaler
    Table 5. Key Players of Insulin Patch & Pump
    Table 6. Global Needle Free Diabetes Management Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Needle Free Diabetes Management Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Needle Free Diabetes Management Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Needle Free Diabetes Management Market Share by Region (2018-2023)
    Table 10. Global Needle Free Diabetes Management Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Needle Free Diabetes Management Market Share by Region (2024-2029)
    Table 12. Needle Free Diabetes Management Market Trends
    Table 13. Needle Free Diabetes Management Market Drivers
    Table 14. Needle Free Diabetes Management Market Challenges
    Table 15. Needle Free Diabetes Management Market Restraints
    Table 16. Global Needle Free Diabetes Management Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Needle Free Diabetes Management Market Share by Players (2018-2023)
    Table 18. Global Top Needle Free Diabetes Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle Free Diabetes Management as of 2022)
    Table 19. Ranking of Global Top Needle Free Diabetes Management Companies by Revenue (US$ Million) in 2022
    Table 20. Global 5 Largest Players Market Share by Needle Free Diabetes Management Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Needle Free Diabetes Management Product Solution and Service
    Table 23. Date of Enter into Needle Free Diabetes Management Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Needle Free Diabetes Management Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Needle Free Diabetes Management Revenue Market Share by Type (2018-2023)
    Table 27. Global Needle Free Diabetes Management Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Needle Free Diabetes Management Revenue Market Share by Type (2024-2029)
    Table 29. Global Needle Free Diabetes Management Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Needle Free Diabetes Management Revenue Market Share by Application (2018-2023)
    Table 31. Global Needle Free Diabetes Management Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Needle Free Diabetes Management Revenue Market Share by Application (2024-2029)
    Table 33. North America Needle Free Diabetes Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 34. North America Needle Free Diabetes Management Market Size by Country (2018-2023) & (US$ Million)
    Table 35. North America Needle Free Diabetes Management Market Size by Country (2024-2029) & (US$ Million)
    Table 36. Europe Needle Free Diabetes Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Europe Needle Free Diabetes Management Market Size by Country (2018-2023) & (US$ Million)
    Table 38. Europe Needle Free Diabetes Management Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Asia-Pacific Needle Free Diabetes Management Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Asia-Pacific Needle Free Diabetes Management Market Size by Region (2018-2023) & (US$ Million)
    Table 41. Asia-Pacific Needle Free Diabetes Management Market Size by Region (2024-2029) & (US$ Million)
    Table 42. Latin America Needle Free Diabetes Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Latin America Needle Free Diabetes Management Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Needle Free Diabetes Management Market Size by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Needle Free Diabetes Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Middle East & Africa Needle Free Diabetes Management Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Middle East & Africa Needle Free Diabetes Management Market Size by Country (2024-2029) & (US$ Million)
    Table 48. Zogenix Company Detail
    Table 49. Zogenix Business Overview
    Table 50. Zogenix Needle Free Diabetes Management Product
    Table 51. Zogenix Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 52. Zogenix Recent Development
    Table 53. 3M Company Detail
    Table 54. 3M Business Overview
    Table 55. 3M Needle Free Diabetes Management Product
    Table 56. 3M Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 57. 3M Recent Development
    Table 58. Antares Pharma Inc. Company Detail
    Table 59. Antares Pharma Inc. Business Overview
    Table 60. Antares Pharma Inc. Needle Free Diabetes Management Product
    Table 61. Antares Pharma Inc. Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 62. Antares Pharma Inc. Recent Development
    Table 63. Glide Pharmaceutical Technologies Company Detail
    Table 64. Glide Pharmaceutical Technologies Business Overview
    Table 65. Glide Pharmaceutical Technologies Needle Free Diabetes Management Product
    Table 66. Glide Pharmaceutical Technologies Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 67. Glide Pharmaceutical Technologies Recent Development
    Table 68. Injex Pharma AG Company Detail
    Table 69. Injex Pharma AG Business Overview
    Table 70. Injex Pharma AG Needle Free Diabetes Management Product
    Table 71. Injex Pharma AG Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 72. Injex Pharma AG Recent Development
    Table 73. Pharmajet, Inc. Company Detail
    Table 74. Pharmajet, Inc. Business Overview
    Table 75. Pharmajet, Inc. Needle Free Diabetes Management Product
    Table 76. Pharmajet, Inc. Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 77. Pharmajet, Inc. Recent Development
    Table 78. Bioject Medical Technologies Company Detail
    Table 79. Bioject Medical Technologies Business Overview
    Table 80. Bioject Medical Technologies Needle Free Diabetes Management Product
    Table 81. Bioject Medical Technologies Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 82. Bioject Medical Technologies Recent Development
    Table 83. Medtronic Company Detail
    Table 84. Medtronic Business Overview
    Table 85. Medtronic Needle Free Diabetes Management Product
    Table 86. Medtronic Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 87. Medtronic Recent Development
    Table 88. Johnson & Johnson Company Detail
    Table 89. Johnson & Johnson Business Overview
    Table 90. Johnson & Johnson Needle Free Diabetes Management Product
    Table 91. Johnson & Johnson Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 92. Johnson & Johnson Recent Development
    Table 93. Pancreum LLC Company Detail
    Table 94. Pancreum LLC Business Overview
    Table 95. Pancreum LLC Needle Free Diabetes Management Product
    Table 96. Pancreum LLC Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 97. Pancreum LLC Recent Development
    Table 98. Tandem Diabetes Care Company Detail
    Table 99. Tandem Diabetes Care Business Overview
    Table 100. Tandem Diabetes Care Needle Free Diabetes Management Product
    Table 101. Tandem Diabetes Care Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 102. Tandem Diabetes Care Recent Development
    Table 103. JDRF Company Detail
    Table 104. JDRF Business Overview
    Table 105. JDRF Needle Free Diabetes Management Product
    Table 106. JDRF Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 107. JDRF Recent Development
    Table 108. Akra Dermojet Company Detail
    Table 109. Akra Dermojet Business Overview
    Table 110. Akra Dermojet Needle Free Diabetes Management Product
    Table 111. Akra Dermojet Revenue in Needle Free Diabetes Management Business (2018-2023) & (US$ Million)
    Table 112. Akra Dermojet Recent Development
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Needle Free Diabetes Management Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Needle Free Diabetes Management Market Share by Type: 2022 VS 2029
    Figure 3. Insulin Jet Injector Features
    Figure 4. Insulin Pen Features
    Figure 5. Insulin Inhaler Features
    Figure 6. Insulin Patch & Pump Features
    Figure 7. Global Needle Free Diabetes Management Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Needle Free Diabetes Management Market Share by Application: 2022 VS 2029
    Figure 9. Hospitals Case Studies
    Figure 10. Clinics Case Studies
    Figure 11. Other Case Studies
    Figure 12. Needle Free Diabetes Management Report Years Considered
    Figure 13. Global Needle Free Diabetes Management Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Needle Free Diabetes Management Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Needle Free Diabetes Management Market Share by Region: 2022 VS 2029
    Figure 16. Global Needle Free Diabetes Management Market Share by Players in 2022
    Figure 17. Global Top Needle Free Diabetes Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle Free Diabetes Management as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Needle Free Diabetes Management Revenue in 2022
    Figure 19. North America Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Needle Free Diabetes Management Market Share by Country (2018-2029)
    Figure 21. United States Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Needle Free Diabetes Management Market Share by Country (2018-2029)
    Figure 25. Germany Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. France Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. U.K. Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Italy Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Russia Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Nordic Countries Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Needle Free Diabetes Management Market Share by Region (2018-2029)
    Figure 33. China Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Japan Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. South Korea Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Southeast Asia Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. India Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Australia Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Needle Free Diabetes Management Market Share by Country (2018-2029)
    Figure 41. Mexico Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Brazil Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Needle Free Diabetes Management Market Share by Country (2018-2029)
    Figure 45. Turkey Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Saudi Arabia Needle Free Diabetes Management Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Zogenix Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 48. 3M Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 49. Antares Pharma Inc. Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 50. Glide Pharmaceutical Technologies Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 51. Injex Pharma AG Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 52. Pharmajet, Inc. Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 53. Bioject Medical Technologies Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 54. Medtronic Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 55. Johnson & Johnson Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 56. Pancreum LLC Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 57. Tandem Diabetes Care Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 58. JDRF Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 59. Akra Dermojet Revenue Growth Rate in Needle Free Diabetes Management Business (2018-2023)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure